I. Konings

What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic breast cancer? A retrospective cohort study.

H. Meijers-Heijboer, J. V. van Waesberghe, H. Verheul, 2015, Cancer epidemiology.

S electing the o ptimal positio n of CDK4/6 i nhibitors in hormone receptor-positive a dvanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

A. Jager, V. Noort, I. Konings, 2018 .

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

A. Jager, F. Erdkamp, A. Haringhuizen, 2018, BMC Cancer.

Five new cases of breast cancer in transsexual persons

P. Lips, L. Gooren, I. Konings, 2015, Andrologia.

Abstract OT2-07-08: Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

A. Jager, S. Linn, V. Tjan-Heijnen, 2018 .

Selecting the optimal position of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer – the SONIA study: study protocol for a randomized controlled trial

A. Jager, F. Erdkamp, A. Haringhuizen, 2018, BMC Cancer.

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

M. Kok, E. Chmielik, R. Rietbroek, 2024, ESMO open.